Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,611 | 300 | 99.0% |
| Education | $57.29 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,248 | 102 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $763.79 | 36 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $734.84 | 23 | $0 (2024) |
| ITI, Inc. | $432.58 | 27 | $0 (2023) |
| Axsome Therapeutics, Inc. | $400.30 | 12 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $369.32 | 17 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $230.39 | 16 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $225.80 | 11 | $0 (2024) |
| Corium, LLC | $222.30 | 9 | $0 (2024) |
| Medline Industries LP | $184.39 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,967 | 94 | ABBVIE INC. ($311.24) |
| 2023 | $2,247 | 112 | ABBVIE INC. ($503.89) |
| 2022 | $1,035 | 62 | Neurocrine Biosciences, Inc. ($298.61) |
| 2021 | $419.24 | 34 | AbbVie Inc. ($196.42) |
All Payment Transactions
302 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Medline Industries LP | — | Food and Beverage | In-kind items and services | $52.07 | General |
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.64 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Narcoplepsy | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: ADHD | ||||||
| 11/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: Central Nervous System | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Almatica Pharma LLC | TERIPARATIDE (Drug), LOREEV XR | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: OSTEOPOROSIS | ||||||
| 10/08/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Neuroscience | ||||||
| 10/07/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $14.37 | General |
| Category: Narcoplepsy | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 68 | 319 | $34,850 | $16,392 |
| 2022 | 2 | 57 | 313 | $31,371 | $16,353 |
| 2021 | 3 | 280 | 505 | $47,132 | $24,331 |
| 2020 | 4 | 366 | 1,095 | $104,501 | $55,024 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 152 | $21,280 | $9,724 | 45.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 34 | 167 | $13,570 | $6,668 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 156 | $18,717 | $9,927 | 53.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 28 | 157 | $12,654 | $6,426 | 50.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 230 | $30,754 | $14,831 | 48.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 134 | 255 | $14,498 | $8,808 | 60.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 20 | $1,880 | $691.80 | 36.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 150 | 482 | $66,034 | $29,904 | 45.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 161 | 545 | $29,430 | $21,547 | 73.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 23 | $4,807 | $2,019 | 42.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 45 | $4,230 | $1,554 | 36.7% |
About Kathy Bryant, CPNP, FNP-BC
Kathy Bryant, CPNP, FNP-BC is a Pediatrics healthcare provider based in Midlothian, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/22/2010. The National Provider Identifier (NPI) number assigned to this provider is 1619277803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kathy Bryant, CPNP, FNP-BC has received a total of $5,668 in payments from pharmaceutical and medical device companies, with $1,967 received in 2024. These payments were reported across 302 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($5,611).
As a Medicare-enrolled provider, Bryant has provided services to 771 Medicare beneficiaries, totaling 2,232 services with total Medicare billing of $112,100. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Family
- Location Midlothian, VA
- Active Since 10/22/2010
- Last Updated 09/12/2024
- Taxonomy Code 363LP0200X
- Entity Type Individual
- NPI Number 1619277803
Products in Payments
- VRAYLAR (Drug) $1,248
- INGREZZA (Drug) $734.84
- CAPLYTA (Drug) $662.97
- SPRAVATO (Drug) $584.56
- Auvelity (Drug) $400.30
- TRINTELLIX (Drug) $369.32
- Austedo XR (Drug) $225.80
- INVEGA SUSTENNA (Drug) $179.23
- LATUDA (Drug) $173.09
- Azstarys (Drug) $157.77
- ABILIFY MAINTENA (Drug) $97.03
- QELBREE (Drug) $85.14
- AZSTARYS (Drug) $64.53
- HETLIOZ (Drug) $60.82
- WAKIX (Drug) $60.33
- FANAPT (Drug) $58.45
- QUVIVIQ (Drug) $55.29
- REXULTI (Drug) $53.30
- TERIPARATIDE (Drug) $36.81
- Dyanavel XR (Drug) $27.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Midlothian
Dr. Patricia Mulreany, M.d, M.D
Pediatrics — Payments: $880,984
Dr. Judith Grossberg, Md, MD
Pediatrics — Payments: $170,697
Dr. Martha Saunders, Md, MD
Pediatrics — Payments: $169,110
Dr. Elizabeth Cullen, Md, MD
Pediatrics — Payments: $168,389
Margaret Sigman
Pediatrics — Payments: $17,303
Dr. Edward Henderson, Do, DO
Pediatrics — Payments: $9,292